Lichen Secondary Metabolite Physciosporin Decreases the Stemness Potential of Colorectal Cancer Cells
Open Access
- 28 November 2019
- journal article
- research article
- Published by MDPI AG in Biomolecules
- Vol. 9 (12) , 797
Abstract
Secondary metabolites of lichens are promising bioresources for candidate anti-cancer drugs. Accordingly, several approaches have been proposed for screening these molecules for novel anti-cancer lead compounds. In this study, we found that a non-toxic concentration of physciosporin, a compound isolated from Pseudocyphellaria granulata, significantly decreased colony formation on soft agar and spheroid formation by CSC221 cancer stem-like cells. Physciosporin also decreased spheroid formation in other colorectal cancer cell lines, including DLD1, Caco2, and HT29. Aldehyde dehydrogenase-1 (ALDH1), the most important cancer stem marker, was sharply downregulated at both the protein and mRNA level following treatment with physciosporin. Physciosporin also decreased the transcriptional activity of the glioma-associated oncogene homolog zinc finger protein (Gli), as well as the Hes1 and CSL promoters, in reporter assays. Moreover, the drug significantly suppressed spheroid formation in CSC221 cells overexpressing Gli1/2 or ΔEN1 (an S2-cleaved but membrane-tethered form of human Notch1) but did not suppress spheroid formation in cells overexpressing both Gli1/2 and ∆EN1, suggesting that physciosporin suppresses colon cancer cell stemness through the Sonic hedgehog and Notch signaling pathways. Together, these results demonstrate for the first time that physciosporin is a potent inhibitor of colorectal cancer cell stemness.Keywords
Funding Information
- National Research Foundation of Korea (NRF-2015R1A4A1041219, NRF-2018R1D1A1B07042608)
- Korea Forest Service (2017024A00-1720-BA01)
This publication has 41 references indexed in Scilit:
- Regulation of stem cell self-renewal and differentiation by Wnt and Notch are conserved throughout the adenoma-carcinoma sequence in the colonMolecular Cancer, 2013
- What makes cancer stem cell markers different?SpringerPlus, 2013
- Targeting Notch, a key pathway for ovarian cancer stem cells, sensitizes tumors to platinum therapyProceedings of the National Academy of Sciences, 2012
- The Wnt/β-catenin pathway regulates growth and maintenance of colonospheresMolecular Cancer, 2010
- Targeting Notch to Target Cancer Stem CellsClinical Cancer Research, 2010
- Review: Targeting the Hedgehog pathway in cancerTherapeutic Advances in Medical Oncology, 2010
- Expansion of CD133+ colon cancer cultures retaining stem cell properties to enable cancer stem cell target discoveryBritish Journal of Cancer, 2010
- The cyclic gene Hes1 contributes to diverse differentiation responses of embryonic stem cellsGenes & Development, 2009
- ALDH1 Is a Marker of Normal and Malignant Human Mammary Stem Cells and a Predictor of Poor Clinical OutcomeCell Stem Cell, 2007
- Hedgehog Signaling and Bmi-1 Regulate Self-renewal of Normal and Malignant Human Mammary Stem CellsCancer Research, 2006